Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Denmark) · Denmark

Erik Bramm

Erik Bramm publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Synthesis and biological activity, Rheumatoid Arthritis Research and Therapies and Drug Transport and Resistance Mechanisms.

OpenAlex
World rank
#6,163,249
of 7,710,434 ranked researchers
Rank in Denmark
#39,338
of 43,819
Works
45
Citations
1.2k
Citations per work
27.1
h-index
19
i10-index 24Top 36% in Molecular Biology
Erik Bramm

What does Erik Bramm research?

Erik Bramm's work is mostly in Medicine (21%), Biochemistry, Genetics and Molecular Biology (16%), Chemistry (11%).

Everything else: 20 works · 44.0% of their workLife Sciences: 11 works · 24.0% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 16.0% of their workMolecular Biology: 7 works · 16.0% of their workImmunology and Microbiology: 4 works · 8.0% of their workImmunology: 4 works · 8.0% of their workHealth Sciences: 9 works · 20.8% of their workMedicine: 9 works · 20.8% of their workOncology: 5 works · 10.4% of their workPharmacology: 3 works · 5.6% of their workRheumatology: 2 works · 4.8% of their workPhysical Sciences: 5 works · 11.2% of their workChemistry: 5 works · 11.2% of their workOrganic Chemistry: 5 works · 11.2% of their workTHEIR WORKErik Bramm45works
Life Sciences24%Physical Sciences11%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2044.0%
    1. Biochemistry, Genetics and Molecular Biology716.0%
    2. Immunology and Microbiology48.0%
    1. Medicine920.8%
    1. Chemistry511.2%
  1. 1Molecular Biology16% of their works
  2. 2Organic Chemistry11% of their works
  3. 3Oncology10% of their works
  4. 4Immunology8% of their works
  5. 5Pharmacology6% of their works
  6. 6Rheumatology5% of their works

Research topics

Which keywords describe Erik Bramm's research?

The keywords of their largest research topics: Inflammation, Cancer, Cardiovascular Risk, Nuclear Receptors, Biological Therapy, Heterocyclic Compounds, Medicinal Chemistry and Rheumatoid Arthritis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Inflammation123 topics
  2. Cancer113 topics
  3. Cardiovascular Risk92 topics
  4. Nuclear Receptors72 topics
  5. Biological Therapy51 topic
  6. Heterocyclic Compounds51 topic
  7. Medicinal Chemistry51 topic
  8. Rheumatoid Arthritis51 topic
  9. ATP-dependent Transporters41 topic
  10. Bone Mineral Density41 topic
  11. Cyclooxygenase-2 Inhibitors41 topic
  12. Deficiency41 topic
  13. Fractures41 topic
  14. Multidrug Resistance41 topic
  15. Prostaglandins41 topic
  16. Vitamin D41 topic
  17. Amino Acid Transporters31 topic
  18. D-Serine31 topic
  19. PPARs31 topic
  20. Peroxisome Proliferator-Activated Receptors31 topic

Where does Erik Bramm work?

Erik Bramm's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.

How many publications and citations does Erik Bramm have?

OpenAlex counts 45 works and 1,218 citations for Erik Bramm, an h-index of 19, ranking #6,163,249 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erik Bramm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.